Model-informed drug development (MIDD) is a powerful quantitative approach that plays an integral role in drug development and regulatory review. While applied throughout the life cycle of …
通过 PBPK 建模优化剂量:最新技术与未来
2024 年 5 月 6 日
Author(s): Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen
Year: 2024 年 4 月 30 日